Relugolix – The novel oral androgen deprivation therapy for prostate cancer

Bibliographic Details
Main Author: Rahul Jena
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Indian Journal of Urology
Online Access:http://www.indianjurol.com/article.asp?issn=0970-1591;year=2020;volume=36;issue=4;spage=327;epage=328;aulast=Jena
_version_ 1828452515669082112
author Rahul Jena
author_facet Rahul Jena
author_sort Rahul Jena
collection DOAJ
first_indexed 2024-12-10T23:53:03Z
format Article
id doaj.art-60c5214913c44b82a5a4057adb3d8dfd
institution Directory Open Access Journal
issn 0970-1591
1998-3824
language English
last_indexed 2024-12-10T23:53:03Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Urology
spelling doaj.art-60c5214913c44b82a5a4057adb3d8dfd2022-12-22T01:28:40ZengWolters Kluwer Medknow PublicationsIndian Journal of Urology0970-15911998-38242020-01-0136432732810.4103/iju.IJU_362_20Relugolix – The novel oral androgen deprivation therapy for prostate cancerRahul Jenahttp://www.indianjurol.com/article.asp?issn=0970-1591;year=2020;volume=36;issue=4;spage=327;epage=328;aulast=Jena
spellingShingle Rahul Jena
Relugolix – The novel oral androgen deprivation therapy for prostate cancer
Indian Journal of Urology
title Relugolix – The novel oral androgen deprivation therapy for prostate cancer
title_full Relugolix – The novel oral androgen deprivation therapy for prostate cancer
title_fullStr Relugolix – The novel oral androgen deprivation therapy for prostate cancer
title_full_unstemmed Relugolix – The novel oral androgen deprivation therapy for prostate cancer
title_short Relugolix – The novel oral androgen deprivation therapy for prostate cancer
title_sort relugolix the novel oral androgen deprivation therapy for prostate cancer
url http://www.indianjurol.com/article.asp?issn=0970-1591;year=2020;volume=36;issue=4;spage=327;epage=328;aulast=Jena
work_keys_str_mv AT rahuljena relugolixthenoveloralandrogendeprivationtherapyforprostatecancer